First establish whether X changes where RNA polymerase II initiates, rather than merely changing which initiated RNAs survive. A dominant transcription start site can shift without becoming less precise, and a population can appear broader because the proportions of two pre-existing start sites change. Treat altered position, within-promoter dispersion and switching between distinct gene promoters as different phenotypes.
Use a dose and short time course of X with vehicle, biological replicates, washout and viability measurements. Map capped ends by CAGE and independently map newly initiated RNA with GRO-cap or another suitably validated nascent-start assay. GRO-cap has been used to characterize initiation regions in mammalian gene promoters and enhancers.[ref] Confirm selected ends with an independent targeted method that distinguishes capped starts from processed RNA ends. Use external standards and control cap recovery; if X inhibits capping, a capped-end assay can lose genuine starts. Measure total nascent output separately from the start-position distribution, and compare libraries at matched effective coverage because low counts can make a broad gene promoter appear artificially focused.
Within a fixed gene promoter window, let be the fraction of initiation events at coordinate . Quantify dominant position, central width and, if useful, Shannon entropy
A one-base shift of a single occupied start changes while leaving ; splitting equally between two positions increases dispersion and gives . Compare complete distributions with sampling uncertainty rather than interpreting one summary alone. Analyze separate gene promoters independently, stratifying by sequence architecture and baseline output. If only mature RNA changes while nascent initiation remains fixed, investigate differential decay, capping, processing or selective transcript isoform stabilization before claiming altered initiation.
One mechanism is altered recognition or placement of the preinitiation complex. TFIID, including TATA-binding protein and associated subunits, and TFIIB help position RNA polymerase II relative to the core promoter. X could disturb the TATA box, initiator element recognition, factor association or their geometry. Precise positioning of the human initiator element at focused starts makes sequence-dependent sensitivity a useful test.[ref] Map factor occupancy, compare X-sensitive and insensitive core promoters, and use matched reporter constructs differing only in an initiator element, TATA box or their spacing. A reporter must have its ends mapped: light output alone cannot reveal an altered transcription start site. Reconstitute initiation on naked DNA with purified factors and add X. Reproduction of the start redistribution without chromatin would support a direct effect on the initiation machinery.
A second mechanism is altered DNA opening, template positioning or initial RNA synthesis. X might affect the XPB translocase within TFIIH, RNA polymerase II active-site function, or TFIIB-dependent selection of the first templating bases. Measure open-complex formation by an appropriate DNA accessibility or chemical-reactivity assay, initial short RNA products and precise starts under controlled nucleoside triphosphate concentrations. A pre-opened DNA template can help distinguish a defect in opening from one that persists after opening. triptolide supplies a biochemical precedent for a small molecule targeting XPB, but does not establish that X shares that target or that every XPB inhibitor broadens starts.[ref] Mammalian initiation should be tested directly; extensive scanning rules established in a different organism cannot simply be assumed to apply.
A third mechanism is a change in the chromatin landscape or DNA supercoiling. Altered nucleosome positioning could expose cryptic gene promoters, while changed histone acetylation or chromatin remodelling could broaden the region accessible to the preinitiation complex. Map chromatin accessibility, nucleosomes and relevant histone modifications before and soon after X treatment. Compare naked and nucleosomal DNA templates carrying the same core promoter; mutate the proposed chromatin remodelling factor or use acute depletion to test whether it is required. For a proposed topoisomerase effect, compare relaxed and supercoiled templates and measure DNA supercoiling directly. Occupancy changes that follow initiation changes can be consequences, so temporal order matters.
A fourth route is indirect alteration of factor supply or activity: X might change nucleoside triphosphate pools, phosphorylation of initiation machinery, or the abundance of a limiting transcription factor. Measure candidate metabolites and protein modifications, test rapid versus delayed onset, and restore the proposed limiting input. Altered promoter-proximal pausing can change the recovery of nascent products without moving the original start; compare initiation-specific maps with downstream engaged-RNA polymerase II profiles. A change that disappears after controlling RNA lifetime or pausing is not evidence for loss of start-site selection.
Finally, identify the direct molecular target through binding or engagement assays and a resistant mutant that retains normal baseline function. Require the resistant version to rescue the start-position phenotype at an X concentration that affects the normal version; overexpression rescue alone can reflect sequestration of the compound. An acute genetic perturbation should phenocopy X, and purified biochemical assays should reproduce the relevant effect. Convergent evidence from nascent starts, controlled templates and target-specific rescue distinguishes direct selection defects from secondary changes in gene expression.
Bacterial and eukaryotic replication obey the same chemical constraints but use different replication machines, initiation controls and chromosome-management strategies. Both perform semiconservative replication, extend new DNA in the direction from a paired end, and therefore require repeated initiation on the lagging template. A useful comparison uses Escherichia coli and nuclear replication in a conventional eukaryote, while recognising that neither represents every organism in its group.
At an E. coli origin of replication, DnaA helps open oriC and promotes assembly of the initiation machinery. The DnaB DNA helicase is loaded with the assistance of loading factors, and two replication forks move away from the origin. Initiation responds to growth and the nucleotide-bound state of DnaA, with additional controls limiting immediate reinitiation. A bacterial chromosome need not always be single and circular: some bacteria have several replicons or linear chromosomes. Fast-growing bacteria can also begin a new round before the preceding round has finished, so replication and biological cell division do not have a universal one-round-to-one-division temporal relationship.
Nuclear eukaryotic chromosomes generally use many origin of replication sites. In G1 phase, the origin recognition complex, Cdc6 and Cdt1 load MCM2-7 around double-stranded DNA. This is replication origin licensing, not yet active replication fork movement. During S phase, cyclin-dependent kinases and Dbf4-dependent kinase promote assembly of the active CMG helicase, containing Cdc45, MCM2-7 and GINS. Elevated kinase activity also suppresses new licensing, separating origin competence from origin firing.
Purified budding-yeast reconstitution demonstrated these opposing kinase functions: cyclin-dependent kinase could inhibit DNA helicase loading while promoting assembly of active replication machinery after licensing, and Dbf4-dependent kinase supplied another required input. Ordered addition, component omission and kinase-dependence experiments establish biochemical requirements more directly than colocalisation in an S phase cell nucleus.[ref] This protects a multi-origin genome against DNA rereplication. Not every licensed origin fires: neighbouring replication forks may replicate a licensed site passively, and unused licensed origins can provide reserve initiation capacity under stress.
The two helicases are distinct molecular solutions. In the conventional comparison, bacterial DnaB translocates on the lagging strand template, whereas the CMG helicase travels on the leading strand template. Their associated proteins also differ. E. coli uses DNA polymerase III with the beta sliding clamp, a clamp loader, DnaG primase and single-stranded DNA-binding protein. In conventional nuclear eukaryotic replication, DNA polymerase alpha-primase begins synthesis, DNA polymerase epsilon primarily extends the leading strand and DNA polymerase delta primarily extends the lagging strand, supported by PCNA, RFC and replication protein A. These are predominant assignments in the standard system, not an assertion that polymerases can never exchange roles during initiation, repair or stress.
Both systems must repeatedly make and mature Okazaki fragments. In E. coli, DnaG supplies an RNA primer, and DNA polymerase I participates in primer removal and gap filling before DNA ligase seals the backbone. Nuclear eukaryotic initiation uses a short RNA segment followed by DNA made by DNA polymerase alpha-primase. Subsequent strand-displacement synthesis, FEN1 and other processing activities remove primer-containing material, and DNA ligase completes joining. Eukaryotic fragments are generally shorter and their formation is integrated with nucleosome assembly; bacterial and eukaryotic lagging strand maturation should not be reduced to identical protein names with different labels.
A shared replication fork architecture does not imply a perfectly rigid, synchronised machine. single-molecule fluorescence microscopy of reconstituted E. coli replication found that leading- and lagging strand polymerases could pause and change rates independently, while DNA helicase behaviour allowed recoupling. This shows why similar average synthesis rates do not prove lockstep molecular progression.[ref] Omission controls establish which reaction requires a component, but a purified short-template assay cannot reproduce every obstacle of a living chromosome.
Chromosome context creates further differences. Nuclear DNA is packaged into chromatin, requiring nucleosome disassembly and reassembly and coordination with replication-associated inheritance of chromatin states. Multiple linear chromosomes also create an end-replication problem, commonly addressed by telomerase and specialised telomere maintenance. Bacterial circular chromosomes avoid that particular end problem but still require resolution of DNA supercoiling, DNA catenanes and chromosome dimers. DNA topoisomerases manage topology in both groups. Converging replication forks terminate replication in both; the Tus-Ter system is a specific feature of certain bacteria, including E. coli, rather than a universal bacterial termination mechanism.
Finally, replication is embedded in different cellular schedules. Bacterial synthesis shares the cellular compartment with transcription and must manage collisions with it; nuclear eukaryotic replication also encounters transcription and other obstacles, despite the separation of nuclear transcription from cytoplasmic translation. ATR–Chk1 signalling in many eukaryotes couples replication stress to origin use and cell-cycle progression. Bacteria use their own damage and fork-recovery programmes, including the SOS response. Neither system is simply unregulated.
Archaea should not be grouped indiscriminately with bacteria in this comparison: their lack of a cell nucleus does not make their replication machinery bacterial, and several core components have closer relationships to the eukaryotic machinery. Comparative experiments should therefore ask separately about initiation, elongation, fidelity, chromatin handling and completion. Measure newly synthesised products as well as protein recruitment, verify that an apparent initiation defect is not degradation of the template, and distinguish a replication fork's instantaneous speed from whole-genome completion time. The deepest difference is how distinct molecular machines are organised around chromosome architecture and cell-cycle control; the underlying templated chemistry and the need to preserve complete genomes are shared.
Topoisomerase 2026-10-20
An enzyme that changes nucleic-acid topology by transient strand cleavage and resealing. Activity on DNA can change DNA supercoiling.